| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910482803803321 |
|
|
Autore |
Madsen Jacob <1538-1606.> |
|
|
Titolo |
Doctrina de concionandi ratione et caussis eloquentiæ, seu potius ratio discendi, docendique in scholis & & eclesiis, publice prælecta in Academia Hafniensi, in Dania à Iacobo Matthiae ..., Tomus primus, nunc editus opera & studio Andreæ Kragii [[electronic resource]] |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Basel, : Sebastian Henricpetri, 1546-1627, 1589 |
|
|
|
|
|
|
|
Descrizione fisica |
|
Online resource ([4], 124 s.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
KragAnders <1558-1600.> |
AarhusJacob Madsen |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Reproduction of original in Det Kongelige Bibliotek / The Royal Library (Copenhagen). |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910140832103321 |
|
|
Titolo |
Aggregation of therapeutic proteins [[electronic resource] /] / edited by Wei Wang, Christopher J. Roberts |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Hoboken, NJ, : Wiley, c2010 |
|
|
|
|
|
|
|
ISBN |
|
1-118-04358-8 |
1-282-70798-1 |
9786612707988 |
0-470-76982-3 |
0-470-76981-5 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (514 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
WangWei <1957 Mar. 10-> |
RobertsChristopher John <1972-> |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Protein drugs |
Aggregation (Chemistry) |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
AGGREGATION OF THERAPEUTIC PROTEINS; CONTENTS; PREFACE; CONTRIBUTORS; CHAPTER 1: Fundamental Structures and Behaviors of Proteins; CHAPTER 2: Protein Aggregation Pathways, Kinetics, and Thermodynamics; CHAPTER 3: Identification and Impact of Aggregation-Prone Regions in Proteins and Therapeutic Monoclonal Antibodies; CHAPTER 4: External Factors Affecting Protein Aggregation; CHAPTER 5: Experimental Detection and Characterization of Protein Aggregates; CHAPTER 6: Approaches to Control Protein Aggregation during Bulk Production |
CHAPTER 7: Protein Aggregation and Particle Formation: Effects of Formulation, Interfaces, and Drug Product Manufacturing OperationsCHAPTER 8: Approaches to Managing Protein Aggregation in Product Development; CHAPTER 9: Case Studies Involving Protein Aggregation; CHAPTER 10: Aggregation and Immunogenicity of Therapeutic Proteins; CHAPTER 11: Regulatory Perspective on Aggregates as a Product Quality Attribute; INDEX; color plate |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This book gives pharmaceutical scientists an up-to-date resource on |
|
|
|
|
|
|
|
|
|
|
protein aggregation and its consequences, and available methods to control or slow down the aggregation process. While significant progress has been made in the past decade, the current understanding of protein aggregation and its consequences is still immature. Prevention or even moderate inhibition of protein aggregation has been mostly experimental. The knowledge in this book can greatly help pharmaceutical scientists in the development of therapeutic proteins, and also instigate further scientific investigations in this ar |
|
|
|
|
|
| |